Survey benchmarks External Education trends and needs to inform structure, capabilities, strengths and gaps that can be leveraged for planning in your organization.
Last month, Medical Affairs and clinical experts from six organizations came together to help make clinical trials more accessible to and better understood by people facing vitiligo. You can do this in your therapeutic area.
In July, MAPS partnered with APPA Australia , IFAPP Academy and the Medical Science Liaison Society to produce a joint position paper on the role of Medical Science Liaisons in the pharmaceutical industry. September 1st, we hosted a discussion with some of the paper authors to discuss consensus on best practices.
In part two of that first discussion, you'll hear from more of the authors on:
This podcast explores a career path leading to Medical Affairs while covering the benefits and challenges involved in discovering your place within the function.
MAPS Insights Focus Area Working Group (FAWG) members define some of the terms associated with the collection and use of insights as a way to start standardizing the lexicon of the function.
MAPS speaks with Medical Strategy FAWG co-leads Becky Harmon and Simon Kyaga about the emerging strategic opportunities for Medical Affairs.
This MAPS podcast details what medical device cybersecurity is and why you should care.
This MAPS podcast details potential areas for compliant collaboration by MSLs with Academic Drug Developers.
At some point, many people feel they’re simply “not good enough.” Unfortunately, this is such a common occurrence that it has a name: Imposter Syndrome.
“Data doesn’t exist until it is published.” Here, MAPS speaks with MedComm FAWG co-leads about innovations and future directions for Medical Communications within Medical Affairs.